More News

04 Sep 2019 BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs
04 Sep 2019 Boehringer Ingelheim Expands KRAS Cancer Program with Lupin’s Clinical Stage MEK Inhibitor Compound
03 Sep 2019 Vertex to Acquire Semma Therapeutics With a Goal of Developing Curative Cell-Based Treatments for Type 1 Diabetes
03 Sep 2019 Velabs Therapeutics announces strategic partnership with alytas therapeutics to develop a novel immune-based therapy for obesity
03 Sep 2019 Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine
03 Sep 2019 RIKEN and Astellas Enter into Worldwide Exclusive Licensing Agreement for Artificial Adjuvant Vector Cell Technology in Oncology
02 Sep 2019 Valo Therapeutics Acquires PeptiENV Technology from the University of Helsinki
28 Aug 2019 Immatics and Celgene Enter Strategic Collaboration to Develop Novel Adoptive Cell Therapies
28 Aug 2019 Presage Announces Collaboration with Bristol-Myers Squibb for Phase O Studies of Novel Cancer Agents Utilizing CIVO™ Technology
28 Aug 2019 Machavert Pharmaceuticals Signs Exclusive License Agreement to Control RAL GTPase Inhibitors against KRAS Cancers
28 Aug 2019 Ionis licenses hepatitis B program to GSK
27 Aug 2019 Adaptimmune and Noile-Immune Announce Agreement to Develop SPEAR T-Cell Products expressing IL-7 and CCL19 as a next-generation treatment for cancer patients
27 Aug 2019 Zogenix Announces Acquisition of Modis Therapeutics, Inc.
27 Aug 2019 Bristol-Myers Squibb Announces Agreement Between Celgene and Amgen to Divest OTEZLA® for $13.4 Billion
22 Aug 2019 Innovent Enters a Licensing Agreement with Lilly to Develop & Commercialize a Novel Diabetes Medicine in China
20 Aug 2019 Alligator Bioscience Signs Antibody Agreement for Greater China with Biotheus Inc.
20 Aug 2019 OKYO Pharma Announces Collaboration with Prof. Pedram Hamrah to Evaluate Proprietary Lead Compounds as Non-Opioid Analgesics Targeting G-Protein Coupled Receptors
15 Aug 2019 Phio Pharmaceuticals and Helmholtz Zentrum München to Collaborate on Novel Targets for the Use of Self-Delivering RNAi In T Cell and NK Cell Adoptive Cell Therapy Therapeutics
14 Aug 2019 Ultragenyx Announces Partnership with GeneTx to Advance Treatment for Angelman Syndrome
13 Aug 2019 AskBio Acquires Synpromics Ltd. and Expands its Gene Therapy Technology Portfolio
13 Aug 2019 Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.
13 Aug 2019 Pharming acquires exclusive license to CDZ173, a late stage drug for the treatment of APDS
12 Aug 2019 Boehringer Ingelheim and MD Anderson form unique Virtual Research and Development Center to rapidly advance new cancer therapies
12 Aug 2019 RELIEF THERAPEUTICS Holding SA Announces Divestment of its Subsidiary Relief Therapeutics SA to Sonnet BioTherapeutics, Inc. to Ensure the Development of Atexakin Alpha (Interleukin-6)
12 Aug 2019 AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up